Catalyst Wire Dossier Catalyst Wire Dossier

BI 1181181

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 1181181, covering 2014-07-10 to 2014-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181 [Phase 1]

See pricing